© 2020 MJH Life Sciences and OncLive. All rights reserved.
Gary J. Schiller, MD, discusses the challenges with treating patients with hairy cell leukemia and some emerging therapies that could impact clinical practice.
After decades of quiescence, the therapeutic landscape of hairy cell leukemia is undergoing rapid evolution.
Hairy cell leukemia is a rare malignancy for which treatment has progressed significantly in recent years.